We are live on ! Find out more
WGS icon

GeneDx Holdings

86 hedge funds and large institutions have $426M invested in GeneDx Holdings in 2024 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more funds holding in top 10

Funds holding in top 10: 16 (+5)

235% more capital invested

Capital invested by funds: $127M → $426M (+$299M)

233% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 12

118% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 11

85% more call options, than puts

Call options by funds: $3.58M | Put options by funds: $1.93M

48% more funds holding

Funds holding: 5886 (+28)

8.88% more ownership

Funds ownership: 53.39%62.27% (+8.9%)

Holders
86
Holders Change
+28
Holders Change %
+48.28%
% of All Funds
1.24%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.09%
New
40
Increased
24
Reduced
11
Closed
12
Calls
$3.58M
Puts
$1.93M
Net Calls
+$1.65M
Net Calls Change
+$1.83M
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
26
Soleus Capital Management
Connecticut
$2.27M -$13.2M -696,376 -89%
CSS
27
Cubist Systematic Strategies
Connecticut
$2M +$1.24M +65,312 +573%
Northern Trust
28
Northern Trust
Illinois
$1.66M +$99.1K +5,229 +9%
TI
29
Trexquant Investment
Connecticut
$1.64M +$1.19M +62,786 New
N
30
Nuveen
North Carolina
$1.57M +$1.14M +59,961 New
Squarepoint
31
Squarepoint
New York
$1.57M +$631K +33,293 +125%
T. Rowe Price Associates
32
T. Rowe Price Associates
Maryland
$1.23M +$73.7K +3,889 +9%
Calamos Advisors
33
Calamos Advisors
Illinois
$1.14M +$824K +43,488 New
Two Sigma Investments
34
Two Sigma Investments
New York
$1.02M +$442K +23,311 +147%
EI
35
EAM Investors
California
$1.01M +$734K +38,705 New
Bank of New York Mellon
36
Bank of New York Mellon
New York
$991K +$719K +37,918 New
RC
37
RBF Capital
California
$976K -$240K -12,660 -25%
BCM
38
Bridgeway Capital Management
Texas
$964K
CMF
39
Counterpoint Mutual Funds
California
$954K +$692K +36,498 New
Charles Schwab
40
Charles Schwab
California
$951K +$689K +36,368 New
Jane Street
41
Jane Street
New York
$891K +$232K +12,225 +56%
Verition Fund Management
42
Verition Fund Management
Connecticut
$599K +$434K +22,900 New
TDC
43
Thompson Davis & Co
Virginia
$571K -$42.6K -2,250 -9%
LAI
44
Legal Advantage Investments
California
$518K +$375K +19,800 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$480K +$344K +18,136 +8,096%
American Century Companies
46
American Century Companies
Missouri
$451K +$86.7K +4,573 +36%
Bank of America
47
Bank of America
North Carolina
$386K +$279K +14,720 +25,379%
ADIM
48
Alpha DNA Investment Management
Maryland
$363K +$263K +13,875 New
AG
49
Algert Global
California
$356K +$258K +13,602 New
Fidelity Investments
50
Fidelity Investments
Massachusetts
$356K -$3.79K -200 -1%

WGS Hedge Fund Activity: Q2 2024 in Review

86 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q2 2024, worth a combined $426M — up 235% from $127M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new WGS positions and 12 closed out — a net gain of 28 holders — while 24 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $12.8M. The largest seller was Soleus Capital Management, cutting an estimated $13.2M.

  • 86 institutional investors held GeneDx Holdings (WGS) as of Q2 2024, up from 58 in Q1 2024.
  • Funds reported $426M of GeneDx Holdings stock for Q2 2024, up 235% quarter-over-quarter.
  • 40 funds opened new GeneDx Holdings positions in Q2 2024 and 12 closed out, a net change of +28 holders.
  • The largest GeneDx Holdings buyer in Q2 2024 was BlackRock, an estimated $12.8M added.
  • The largest GeneDx Holdings seller in Q2 2024 was Soleus Capital Management, an estimated $13.2M sold.

Based on aggregated 13F filings for Q2 2024.